Jeffrey Bluestone (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Jeffrey Bluestone" in English language version.

refsWebsite
Global rank English rank
1st place
1st place
low place
low place
2nd place
2nd place
4th place
4th place
5,479th place
3,911th place
low place
6,978th place
low place
low place
11th place
8th place
488th place
374th place

biopharmadive.com

brehmcoalition.org

  • Brehm Coalition Staff & Bluestone, Jeffrey (4 August 2016). "About Us / Leadership / Jeffrey Bluestone". BrehmCoalition.org. Archived from the original on 2016-08-16. Retrieved 26 January 2022. Jeffrey Bluestone, M.S., Ph.D., is the Director of the University of California, San Francisco Diabetes Center and the Immune Tolerance Network and is AW and Mary Clausen Distinguished Professor of Medicine, Pathology, Microbiology and Immunology. [He] received his undergraduate degree in biology from Rutgers University and a doctorate in immunology from Cornell University. From there he held positions at the National Institute of Health (NIH) and served as the Director of the Ben May Institute for Cancer Research.[third-party source needed]
  • Brehm Coalition Staff (26 January 2022). "About / Emeritus Members / Jeffrey Bluestone". BrehmCoalition.org. Retrieved 26 January 2022.

columbia.edu

cumc.columbia.edu

  • Conovo, Susan (26 June 2002). "Stopping Diabetes". www.cumc.columbia.edu. No. 11. In Vivo. Archived from the original on 25 January 2017. Retrieved 4 August 2016.

doi.org

  • Walunas, TL; Lenschow, DJ; Bakker, CY; Linsley, PS; Freeman, GJ; Green, JM; Thompson, CB; Bluestone, JA (August 1994). "CTLA-4 can function as a negative regulator of T cell activation". Immunity. 1 (5): 405–13. doi:10.1016/1074-7613(94)90071-x. PMID 7882171.
  • Levisetti, MG; Padrid, PA; Szot, GL; Mittal, N; Meehan, SM; Wardrip, CL; Gray, GS; Bruce, DS; Thistlethwaite JR, Jr; Bluestone, JA (1 December 1997). "Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation". Journal of Immunology. 159 (11): 5187–91. doi:10.4049/jimmunol.159.11.5187. PMID 9548454. S2CID 11604489.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Walunas, TL; Lenschow, DJ; Bakker, CY; Linsley, PS; Freeman, GJ; Green, JM; Thompson, CB; Bluestone, JA (August 1994). "CTLA-4 can function as a negative regulator of T cell activation". Immunity. 1 (5): 405–13. doi:10.1016/1074-7613(94)90071-x. PMID 7882171.
  • Levisetti, MG; Padrid, PA; Szot, GL; Mittal, N; Meehan, SM; Wardrip, CL; Gray, GS; Bruce, DS; Thistlethwaite JR, Jr; Bluestone, JA (1 December 1997). "Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation". Journal of Immunology. 159 (11): 5187–91. doi:10.4049/jimmunol.159.11.5187. PMID 9548454. S2CID 11604489.

semanticscholar.org

api.semanticscholar.org

  • Levisetti, MG; Padrid, PA; Szot, GL; Mittal, N; Meehan, SM; Wardrip, CL; Gray, GS; Bruce, DS; Thistlethwaite JR, Jr; Bluestone, JA (1 December 1997). "Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation". Journal of Immunology. 159 (11): 5187–91. doi:10.4049/jimmunol.159.11.5187. PMID 9548454. S2CID 11604489.

ucsf.edu

profiles.ucsf.edu

  • Bluestone, Jeffrey (January 26, 2022). "Jeffrey Bluestone, PhD". Profiles.UCSF.edu. Retrieved January 26, 2022.

ucsf.edu

web.archive.org

  • Brehm Coalition Staff & Bluestone, Jeffrey (4 August 2016). "About Us / Leadership / Jeffrey Bluestone". BrehmCoalition.org. Archived from the original on 2016-08-16. Retrieved 26 January 2022. Jeffrey Bluestone, M.S., Ph.D., is the Director of the University of California, San Francisco Diabetes Center and the Immune Tolerance Network and is AW and Mary Clausen Distinguished Professor of Medicine, Pathology, Microbiology and Immunology. [He] received his undergraduate degree in biology from Rutgers University and a doctorate in immunology from Cornell University. From there he held positions at the National Institute of Health (NIH) and served as the Director of the Ben May Institute for Cancer Research.[third-party source needed]
  • Conovo, Susan (26 June 2002). "Stopping Diabetes". www.cumc.columbia.edu. No. 11. In Vivo. Archived from the original on 25 January 2017. Retrieved 4 August 2016.

xconomy.com